Seeking Alpha
View as an RSS Feed

Patrick Young  

View Patrick Young's Articles BY TICKER:
  • NeoStem: The Levi Strauss Of Cell Therapy
    Thu, Feb. 12 NBS 50 Comments

    Summary

    • NeoStem's wholly owned subsidiary Progenitor Cell Therapy, LLC is an industry leader in contract development and manufacture of cell therapy products, akin to selling pickaxes during a gold rush.
    • NeoStem does some gold mining of its own, targeting the mother lodes of heart disease and cancer, with therapeutic cell-therapy products entering Phase III trials.
    • NeoStem is undervalued on the basis of PCT and is an attractive partner for big pharma.
  • 3 Small-Cap Growth Industrial Tech Companies
    Sep. 20, 2012 FF, REFR, GTATQ 7 Comments
  • Money Printing Killed The S&P
    Jun. 6, 2012 SPY 49 Comments
  • Taking Stock Of 3 Dividend Plays
    Mar. 6, 2012 SDRL, TGP, TICC 1 Comment
  • The End Of Ordinary Commodity Cycles: ETFs To Play This Emerging Trend
    Feb. 22, 2012 DBB, DBP, GLD 4 Comments
  • ConocoPhillips: An Industry Leader
    Jul. 20, 2011 COP 11 Comments
  • 3 High Yield Stocks That Are Likely to Outperform the Market
    Jul. 8, 2011 TICC, SDRL, TGP 28 Comments
  • XME: My Favorite Way to Play Commodities
    Jul. 7, 2011 XME 12 Comments